Market Cap 2.92B
Revenue (ttm) 0.00
Net Income (ttm) -177.81M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,124,700
Avg Vol 1,468,458
Day's Range N/A - N/A
Shares Out 79.14M
Stochastic %K 23%
Beta 0.40
Analysts Strong Sell
Price Target $49.62

Company Profile

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. The company's clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. It has initiated a Phase 2...

Industry: Biotechnology
Sector: Healthcare
Phone: 888 378 6240
Address:
150 N. Radnor Chester Rd., Suite F200, Radnor, United States
YEHMINGZHU
YEHMINGZHU Dec. 13 at 7:20 PM
$MLYS Lorundorestat is a highly selective Aldosterone Synthase Inhibitor (ASI). It works by targeting the over-production of aldosterone, a hormone that drives high blood pressure in many patients resistant to standard therapies. This trial's results were so impactful they were recognized in the Journal of the American Medical Association (JAMA) "Research of the Year" Roundup. I will be looking for an entry here as I believe it is de risked now. Data anticipated Q1 2026 and this drug is the only one being studied to address OSA. This is there opportunity to turn into a platform therapy. Can break above $50 or $60 on this readout. **No position yet**
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:38 AM
Actionable Trade Alert for $MLYS: Market Context: $MLYS is currently trading at $36.65, significantly below its 60D high of $47.65 and closer to its 60D low of $33.63. The RSI of 23.9 indicates that the stock is oversold, suggesting a potential reversal. The moving averages (MA30 at 40.96 and MA50 at 40.99) indicate a bearish trend, but the extreme RSI presents a buying opportunity. Directional Bias: Given the oversold RSI and proximity to the 60D low, we anticipate a bullish reversal in the near term. Trade Plan: - Suggested Entry: $36.65 - Stop Loss: $34.00 (approximately 7.3% below entry) - Take Profit Targets: 1. $40.00 (9% ROI) 2. $43.00 (17% ROI) 3. $43.00 (17% ROI) Target 3 aligns with a potential recovery towards the MA30 and MA50. Monitor the ATR of 1.89 for volatility. Stay disciplined and adjust as necessary. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 11 at 1:12 AM
$MLYS Current Stock Price: $36.17 Contracts to trade: $35 MLYS Dec 19 2025 Call Entry: $0.40 Exit: $0.79 ROI: 99% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OptionRunners
OptionRunners Dec. 10 at 9:23 PM
$MLYS these got added again into the close. Total of 14,567 contracts today.
0 · Reply
OptionRunners
OptionRunners Dec. 10 at 7:37 PM
$MLYS again .. 35/30/60 this time
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:41 AM
Actionable Trade Alert for $MLYS: Market Context: $MLYS is currently trading at $36.73, significantly below its 60-day high of $47.65, indicating potential for a rebound. The RSI at 18.41 suggests that the stock is oversold, which may lead to a price correction. The moving averages (MA30 at 41.22 and MA50 at 41.09) further support a bullish outlook as the stock is trading below these averages. Directional Bias: Given the oversold RSI and proximity to the 60-day low of $33.63, we anticipate a bullish reversal. Trade Plan: - Suggested Entry: $36.73 - Stop Loss: $34.50 (approx. 6% below entry) - Take Profit Targets: 1. $40.00 (target 1, approx. 8.3% ROI) 2. $43.00 (target 2, approx. 17.5% ROI) 3. $43.00 (target 3, approx. 17.5% ROI) This plan offers a potential ROI of over 17% at target 3 while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
OptionRunners
OptionRunners Dec. 9 at 7:32 PM
$MLYS bear seagulls got added to again here. Originally on 12/3 for $3.35 and now up to $4.44.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:30 AM
Actionable Trade Alert for $MLYS: Market Context: $MLYS closed at $37.96, significantly below its 30-day moving average (MA30) of $41.34 and 50-day moving average (MA50) of $41.13, indicating bearish sentiment. The RSI at 19.06 suggests the stock is oversold, presenting a potential reversal opportunity. Directional Bias: Given the extreme RSI level and proximity to the 60-day low of $33.63, there is a likelihood of a bounce back towards the higher range. The ATR of 2.12 indicates potential volatility, allowing for strategic entry and exit points. Trade Plan: - Suggested Entry: $37.96 (last close) - Stop Loss: $35.00 (below recent support) - Take Profit Targets: 1. $40.00 (5.4% gain) 2. $43.00 (13.6% gain) 3. $44.50 (17.5% gain) Target 3 offers a potential ROI of 17.5% based on the entry price. Monitor closely for price action around the targets. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:29 AM
Actionable Trade Alert for $MLYS: Market Context: $MLYS is currently trading at $38.91, significantly below its 60-day high of $47.65, indicating potential for upward movement. The RSI at 33.27 suggests the stock is oversold, providing a bullish bias for a rebound. The moving averages (MA30 at 41.49 and MA50 at 41.17) indicate resistance levels that could be tested as the price recovers. Directional Bias: The stock is positioned within a range defined by the 60-day high of $47.65 and low of $33.63. With the current price near the lower end and an oversold RSI, a bullish reversal is likely. Trade Plan: - Suggested Entry: $39.00 - Stop Loss: $36.00 (3.8% below entry) - Take Profit Targets: 1. $42.00 (7.7% gain) 2. $44.00 (12.8% gain) 3. $45.50 (17.0% gain) This plan aims for a minimum 17% ROI at the third target while managing risk with a stop loss. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 11:04 PM
Actionable Trade Alert for $MLYS: Market Context: $MLYS is currently trading at $38.91, significantly below its 60-day high of $47.65, indicating potential for upward movement. The RSI at 33.27 suggests the stock is oversold, providing a bullish bias for a rebound. The moving averages (MA30 at 41.49 and MA50 at 41.17) indicate resistance levels that could be tested as the price recovers. Directional Bias: The stock is positioned within a range defined by the 60-day high of $47.65 and low of $33.63. With the current price near the lower end and an oversold RSI, a bullish reversal is likely. Trade Plan: - Suggested Entry: $39.00 - Stop Loss: $36.00 (3.8% below entry) - Take Profit Targets: 1. $42.00 (7.7% gain) 2. $44.00 (12.8% gain) 3. $45.50 (17.0% gain) This plan aims for a minimum 17% ROI at the third target while managing risk with a stop loss. https://privateprofiteers.com
0 · Reply
Latest News on MLYS
3 Potential Biotech Acquisition Targets

Sep 19, 2025, 12:53 PM EDT - 3 months ago

3 Potential Biotech Acquisition Targets

AZN ETNB INCY SNDX TVTX


Mineralys Therapeutics' blood pressure drug meets goal in trials

Mar 10, 2025, 7:12 AM EDT - 9 months ago

Mineralys Therapeutics' blood pressure drug meets goal in trials


YEHMINGZHU
YEHMINGZHU Dec. 13 at 7:20 PM
$MLYS Lorundorestat is a highly selective Aldosterone Synthase Inhibitor (ASI). It works by targeting the over-production of aldosterone, a hormone that drives high blood pressure in many patients resistant to standard therapies. This trial's results were so impactful they were recognized in the Journal of the American Medical Association (JAMA) "Research of the Year" Roundup. I will be looking for an entry here as I believe it is de risked now. Data anticipated Q1 2026 and this drug is the only one being studied to address OSA. This is there opportunity to turn into a platform therapy. Can break above $50 or $60 on this readout. **No position yet**
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:38 AM
Actionable Trade Alert for $MLYS: Market Context: $MLYS is currently trading at $36.65, significantly below its 60D high of $47.65 and closer to its 60D low of $33.63. The RSI of 23.9 indicates that the stock is oversold, suggesting a potential reversal. The moving averages (MA30 at 40.96 and MA50 at 40.99) indicate a bearish trend, but the extreme RSI presents a buying opportunity. Directional Bias: Given the oversold RSI and proximity to the 60D low, we anticipate a bullish reversal in the near term. Trade Plan: - Suggested Entry: $36.65 - Stop Loss: $34.00 (approximately 7.3% below entry) - Take Profit Targets: 1. $40.00 (9% ROI) 2. $43.00 (17% ROI) 3. $43.00 (17% ROI) Target 3 aligns with a potential recovery towards the MA30 and MA50. Monitor the ATR of 1.89 for volatility. Stay disciplined and adjust as necessary. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 11 at 1:12 AM
$MLYS Current Stock Price: $36.17 Contracts to trade: $35 MLYS Dec 19 2025 Call Entry: $0.40 Exit: $0.79 ROI: 99% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OptionRunners
OptionRunners Dec. 10 at 9:23 PM
$MLYS these got added again into the close. Total of 14,567 contracts today.
0 · Reply
OptionRunners
OptionRunners Dec. 10 at 7:37 PM
$MLYS again .. 35/30/60 this time
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:41 AM
Actionable Trade Alert for $MLYS: Market Context: $MLYS is currently trading at $36.73, significantly below its 60-day high of $47.65, indicating potential for a rebound. The RSI at 18.41 suggests that the stock is oversold, which may lead to a price correction. The moving averages (MA30 at 41.22 and MA50 at 41.09) further support a bullish outlook as the stock is trading below these averages. Directional Bias: Given the oversold RSI and proximity to the 60-day low of $33.63, we anticipate a bullish reversal. Trade Plan: - Suggested Entry: $36.73 - Stop Loss: $34.50 (approx. 6% below entry) - Take Profit Targets: 1. $40.00 (target 1, approx. 8.3% ROI) 2. $43.00 (target 2, approx. 17.5% ROI) 3. $43.00 (target 3, approx. 17.5% ROI) This plan offers a potential ROI of over 17% at target 3 while managing risk effectively. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
OptionRunners
OptionRunners Dec. 9 at 7:32 PM
$MLYS bear seagulls got added to again here. Originally on 12/3 for $3.35 and now up to $4.44.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:30 AM
Actionable Trade Alert for $MLYS: Market Context: $MLYS closed at $37.96, significantly below its 30-day moving average (MA30) of $41.34 and 50-day moving average (MA50) of $41.13, indicating bearish sentiment. The RSI at 19.06 suggests the stock is oversold, presenting a potential reversal opportunity. Directional Bias: Given the extreme RSI level and proximity to the 60-day low of $33.63, there is a likelihood of a bounce back towards the higher range. The ATR of 2.12 indicates potential volatility, allowing for strategic entry and exit points. Trade Plan: - Suggested Entry: $37.96 (last close) - Stop Loss: $35.00 (below recent support) - Take Profit Targets: 1. $40.00 (5.4% gain) 2. $43.00 (13.6% gain) 3. $44.50 (17.5% gain) Target 3 offers a potential ROI of 17.5% based on the entry price. Monitor closely for price action around the targets. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:29 AM
Actionable Trade Alert for $MLYS: Market Context: $MLYS is currently trading at $38.91, significantly below its 60-day high of $47.65, indicating potential for upward movement. The RSI at 33.27 suggests the stock is oversold, providing a bullish bias for a rebound. The moving averages (MA30 at 41.49 and MA50 at 41.17) indicate resistance levels that could be tested as the price recovers. Directional Bias: The stock is positioned within a range defined by the 60-day high of $47.65 and low of $33.63. With the current price near the lower end and an oversold RSI, a bullish reversal is likely. Trade Plan: - Suggested Entry: $39.00 - Stop Loss: $36.00 (3.8% below entry) - Take Profit Targets: 1. $42.00 (7.7% gain) 2. $44.00 (12.8% gain) 3. $45.50 (17.0% gain) This plan aims for a minimum 17% ROI at the third target while managing risk with a stop loss. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 11:04 PM
Actionable Trade Alert for $MLYS: Market Context: $MLYS is currently trading at $38.91, significantly below its 60-day high of $47.65, indicating potential for upward movement. The RSI at 33.27 suggests the stock is oversold, providing a bullish bias for a rebound. The moving averages (MA30 at 41.49 and MA50 at 41.17) indicate resistance levels that could be tested as the price recovers. Directional Bias: The stock is positioned within a range defined by the 60-day high of $47.65 and low of $33.63. With the current price near the lower end and an oversold RSI, a bullish reversal is likely. Trade Plan: - Suggested Entry: $39.00 - Stop Loss: $36.00 (3.8% below entry) - Take Profit Targets: 1. $42.00 (7.7% gain) 2. $44.00 (12.8% gain) 3. $45.50 (17.0% gain) This plan aims for a minimum 17% ROI at the third target while managing risk with a stop loss. https://privateprofiteers.com
0 · Reply
OptionRunners
OptionRunners Dec. 5 at 8:15 PM
$MLYS these got added to again earlier. The $40's (long leg) are ITM
0 · Reply
OptionRunners
OptionRunners Dec. 3 at 4:10 PM
$MLYS buyer of the March 20th 2026 $40/$30/$60 bear seagulls 3,500 times for $3.35
0 · Reply
Uneducated_Trader
Uneducated_Trader Nov. 17 at 5:36 PM
$MLYS bought last week. Thank you mlys
0 · Reply
medguy
medguy Nov. 14 at 4:24 PM
$MLYS and $DGNX looking for reversal
0 · Reply
Arcides
Arcides Nov. 14 at 3:09 PM
$MLYS standed good yesterday but today is falling on high volume.
0 · Reply
_www_larval_com_
_www_larval_com_ Nov. 14 at 2:42 PM
$SGML 17%[10%] $CMBM 12%[16%] $MLYS 9%[-12%] $AVXL 9%[-34%] $TSSI -8%[-41%] most notable movement within the first minutes of trading.
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 11:46 AM
HC Wainwright & Co. updates rating for Mineralys Therapeutics ( $MLYS ) to Buy, target set at 52 → 56.
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 2:27 PM
Wells Fargo has adjusted their stance on Mineralys Therapeutics ( $MLYS ), setting the rating to Overweight with a target price of 50 → 55.
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 11 at 1:50 PM
$MLYS (-1.8% pre) Form S-3ASR Mineralys Therapeutics, https://ooc.bz/l/84089
0 · Reply
Panban
Panban Nov. 11 at 6:20 AM
$MLYS MINERALYS THERAPEUTICS INC - IN ADDITION, OFFERING OF UP TO $300 MLN OF COMMON STOCK
0 · Reply
d_risk
d_risk Nov. 11 at 12:32 AM
$MLYS - Mineralys Therapeutics Inc. Common Stock - 10Q - Updated Risk Factors MLYS drops risks tied to tariffs, inflation, and economic uncertainty, but flags new threats from potential tax law changes and possible FDA/government agency disruptions that could hit financials, product approvals, and stock value. #Biotechnology #EconomicUncertainty #FDADisruptions #TaxLawChanges #RegulatoryRisk 🟢 Added 🟠 Removed https://d-risk.ai/MLYS/10-Q/2025-11-10
0 · Reply
Jakeipedia
Jakeipedia Nov. 10 at 3:59 PM
$MLYS just the beginning!!
0 · Reply